Gilead Operating Income vs Tax Provision Analysis

0QYQ Stock   110.88  0.42  0.38%   
Gilead Sciences financial indicator trend analysis is much more than just examining Gilead Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gilead Sciences is a good investment. Please check the relationship between Gilead Sciences Operating Income and its Tax Provision accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide.

Operating Income vs Tax Provision

Operating Income vs Tax Provision Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gilead Sciences Operating Income account and Tax Provision. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Gilead Sciences' Operating Income and Tax Provision is 0.93. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Gilead Sciences, assuming nothing else is changed. The correlation between historical values of Gilead Sciences' Operating Income and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Gilead Sciences are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Operating Income i.e., Gilead Sciences' Operating Income and Tax Provision go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Operating Income

Operating Income is the amount of profit realized from Gilead Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Gilead Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.
Most indicators from Gilead Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide.Tax Provision is likely to drop to about 1.5 B in 2025. Selling General Administrative is likely to drop to about 5 B in 2025
 2020 2021 2024 2025 (projected)
Gross Profit20.1B20.7B23.8B21.5B
Total Revenue24.7B27.3B31.4B27.0B

Gilead Sciences fundamental ratios Correlations

0.210.98-0.66-0.4-0.620.270.21-0.290.540.29-0.09-0.010.23-0.11-0.550.93-0.270.34-0.540.090.240.28-0.210.64
0.210.260.220.43-0.5-0.271.00.35-0.18-0.250.53-0.53-0.34-0.6-0.640.480.29-0.170.64-0.58-0.24-0.260.25-0.18
0.980.26-0.67-0.43-0.60.180.26-0.340.540.34-0.150.020.28-0.04-0.520.94-0.320.4-0.50.090.350.39-0.30.58
-0.660.22-0.670.660.410.220.220.48-0.51-0.320.37-0.16-0.380.070.46-0.660.37-0.350.78-0.24-0.29-0.610.47-0.48
-0.40.43-0.430.660.3-0.050.430.96-0.92-0.90.93-0.83-0.93-0.540.0-0.30.92-0.890.63-0.86-0.82-0.80.93-0.7
-0.62-0.5-0.60.410.3-0.04-0.50.38-0.5-0.30.08-0.01-0.280.430.7-0.740.37-0.350.09-0.06-0.26-0.30.32-0.25
0.27-0.270.180.22-0.05-0.04-0.27-0.140.20.17-0.110.190.090.410.38-0.04-0.190.13-0.330.290.19-0.220.080.27
0.211.00.260.220.43-0.5-0.270.35-0.18-0.250.53-0.53-0.34-0.6-0.640.480.29-0.170.64-0.58-0.24-0.260.25-0.18
-0.290.35-0.340.480.960.38-0.140.35-0.93-0.950.95-0.88-0.97-0.57-0.08-0.210.99-0.940.48-0.9-0.9-0.790.96-0.59
0.54-0.180.54-0.51-0.92-0.50.2-0.18-0.930.94-0.840.80.930.45-0.130.44-0.940.95-0.450.840.810.69-0.870.78
0.29-0.250.34-0.32-0.9-0.30.17-0.25-0.950.94-0.930.920.980.650.130.2-0.981.0-0.310.920.920.73-0.930.66
-0.090.53-0.150.370.930.08-0.110.530.95-0.84-0.93-0.95-0.96-0.75-0.310.030.94-0.90.45-0.95-0.89-0.760.94-0.55
-0.01-0.530.02-0.16-0.83-0.010.19-0.53-0.880.80.92-0.950.940.770.41-0.15-0.910.88-0.290.990.830.65-0.850.52
0.23-0.340.28-0.38-0.93-0.280.09-0.34-0.970.930.98-0.960.940.630.160.15-0.980.97-0.360.940.920.81-0.960.59
-0.11-0.6-0.040.07-0.540.430.41-0.6-0.570.450.65-0.750.770.630.75-0.35-0.60.61-0.320.760.70.39-0.560.36
-0.55-0.64-0.520.460.00.70.38-0.64-0.08-0.130.13-0.310.410.160.75-0.77-0.110.06-0.040.380.290.08-0.07-0.26
0.930.480.94-0.66-0.3-0.74-0.040.48-0.210.440.20.03-0.150.15-0.35-0.77-0.190.27-0.32-0.090.150.28-0.190.49
-0.270.29-0.320.370.920.37-0.190.290.99-0.94-0.980.94-0.91-0.98-0.6-0.11-0.19-0.970.38-0.92-0.92-0.740.95-0.6
0.34-0.170.4-0.35-0.89-0.350.13-0.17-0.940.951.0-0.90.880.970.610.060.27-0.97-0.290.880.910.74-0.940.67
-0.540.64-0.50.780.630.09-0.330.640.48-0.45-0.310.45-0.29-0.36-0.32-0.04-0.320.38-0.29-0.42-0.33-0.430.35-0.49
0.09-0.580.09-0.24-0.86-0.060.29-0.58-0.90.840.92-0.950.990.940.760.38-0.09-0.920.88-0.420.820.63-0.830.59
0.24-0.240.35-0.29-0.82-0.260.19-0.24-0.90.810.92-0.890.830.920.70.290.15-0.920.91-0.330.820.83-0.920.39
0.28-0.260.39-0.61-0.8-0.3-0.22-0.26-0.790.690.73-0.760.650.810.390.080.28-0.740.74-0.430.630.83-0.870.24
-0.210.25-0.30.470.930.320.080.250.96-0.87-0.930.94-0.85-0.96-0.56-0.07-0.190.95-0.940.35-0.83-0.92-0.87-0.49
0.64-0.180.58-0.48-0.7-0.250.27-0.18-0.590.780.66-0.550.520.590.36-0.260.49-0.60.67-0.490.590.390.24-0.49
Click cells to compare fundamentals

Gilead Sciences Account Relationship Matchups

Gilead Sciences fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets63.7B61.6B68.4B68.0B78.1B73.0B
Total Current Liabilities9.8B11.4B11.6B11.2B12.9B12.1B
Total Stockholder Equity21.4B22.5B18.2B21.1B19.0B16.6B
Retained Earnings19.4B14.4B16.3B15.7B14.1B13.8B
Cash17.9B11.6B6.0B7.8B7.0B8.2B
Other Assets3.1B1.7B2.9B2.9B3.4B2.9B
Cash And Short Term Investments30.1B24.4B7.4B7.8B7.0B6.7B
Net Receivables3.6B4.9B4.5B4.8B5.5B4.6B
Inventory922M1.7B1.6B1.5B1.7B1.3B
Other Stockholder Equity85M(60M)83M2M2.3M2.2M
Total Liab42.3B39.1B50.2B46.9B53.9B50.2B
Total Current Assets30.3B16.0B14.8B14.4B13.0B19.1B
Intangible Assets15.7B13.8B33.1B33.5B38.5B24.9B
Property Plant Equipment5.2B5.6B5.7B6.0B6.9B5.4B
Other Current Liab430M1.3B2.3B1.4B1.6B1.3B
Other Liab6.5B9.5B9.6B7.3B8.4B8.8B
Net Tangible Assets4.6B(23.0B)(20.7B)(16.0B)(14.4B)(15.1B)
Accounts Payable713M844M705M905M1.0B870.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Gilead Stock Analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.